• Je něco špatně v tomto záznamu ?

Deazaflavin Inhibitors of TDP2 with Cellular Activity Can Affect Etoposide Influx and/or Efflux

E. Komulainen, L. Pennicott, D. Le Grand, KW. Caldecott,

. 2019 ; 14 (6) : 1110-1114. [pub] 20190516

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc20006361

Grantová podpora
C6563/A16771 Cancer Research UK - United Kingdom
110578/Z/15/Z Wellcome Trust - United Kingdom

Tyrosyl DNA phosphodiesterase 2 (TDP2) facilitates the repair of topoisomerase II (TOP2)-linked DNA double-strand breaks and, as a consequence, is required for cellular resistance to TOP2 "poisons". Recently, a deazaflavin series of compounds were identified as potent inhibitors of TDP2, in vitro. Here, however, we show that while some deazaflavins can induce cellular sensitivity to the TOP2 poison etoposide, they do so independently of TDP2 status. Consistent with this, both the cellular level of etoposide-induced TOP2 cleavage complexes and the intracellular concentration of etoposide was increased by incubation with deazaflavin, suggesting an impact of these compounds on etoposide uptake/efflux. In addition, deazaflavin failed to increase the level of TOP2 cleavage complexes or sensitivity induced by m-AMSA, which is a different class of TOP2 poison to which TDP2-defective cells are also sensitive. In conclusion, while deazaflavins are potent inhibitors of TDP2 in vitro, their limited cell permeability and likely interference with etoposide influx/efflux limits their utility in cells.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20006361
003      
CZ-PrNML
005      
20200526083859.0
007      
ta
008      
200511s2019 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1021/acschembio.9b00144 $2 doi
035    __
$a (PubMed)31091068
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Komulainen, Emilia $u Genome Damage and Stability Centre, School of Life Sciences , University of Sussex , Falmer, Brighton , BN1 9RQ , United Kingdom.
245    10
$a Deazaflavin Inhibitors of TDP2 with Cellular Activity Can Affect Etoposide Influx and/or Efflux / $c E. Komulainen, L. Pennicott, D. Le Grand, KW. Caldecott,
520    9_
$a Tyrosyl DNA phosphodiesterase 2 (TDP2) facilitates the repair of topoisomerase II (TOP2)-linked DNA double-strand breaks and, as a consequence, is required for cellular resistance to TOP2 "poisons". Recently, a deazaflavin series of compounds were identified as potent inhibitors of TDP2, in vitro. Here, however, we show that while some deazaflavins can induce cellular sensitivity to the TOP2 poison etoposide, they do so independently of TDP2 status. Consistent with this, both the cellular level of etoposide-induced TOP2 cleavage complexes and the intracellular concentration of etoposide was increased by incubation with deazaflavin, suggesting an impact of these compounds on etoposide uptake/efflux. In addition, deazaflavin failed to increase the level of TOP2 cleavage complexes or sensitivity induced by m-AMSA, which is a different class of TOP2 poison to which TDP2-defective cells are also sensitive. In conclusion, while deazaflavins are potent inhibitors of TDP2 in vitro, their limited cell permeability and likely interference with etoposide influx/efflux limits their utility in cells.
650    _2
$a zvířata $7 D000818
650    _2
$a aza sloučeniny $x chemie $7 D001372
650    _2
$a biologický transport $7 D001692
650    _2
$a buněčné linie $7 D002460
650    _2
$a kur domácí $7 D002645
650    _2
$a DNA vazebné proteiny $x antagonisté a inhibitory $7 D004268
650    _2
$a etoposid $x farmakokinetika $7 D005047
650    _2
$a flaviny $x chemie $x farmakokinetika $x farmakologie $7 D005415
650    _2
$a lidé $7 D006801
650    _2
$a fosfodiesterasy $7 D010727
650    _2
$a knihovny malých molekul $x farmakologie $7 D054852
650    _2
$a inhibitory topoisomerasy II $x farmakokinetika $7 D059005
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Pennicott, Lewis $u Sussex Drug Discovery Centre, School of Life Sciences , University of Sussex , Falmer, Brighton , BN1 9RQ , United Kingdom.
700    1_
$a Le Grand, Darren $u Sussex Drug Discovery Centre, School of Life Sciences , University of Sussex , Falmer, Brighton , BN1 9RQ , United Kingdom.
700    1_
$a Caldecott, Keith W $u Genome Damage and Stability Centre, School of Life Sciences , University of Sussex , Falmer, Brighton , BN1 9RQ , United Kingdom. Department of Genome Dynamics , Institute of Molecular Genetics of the Czech Academy of Sciences , 142 20 Prague , 4, Czech Republic.
773    0_
$w MED00179502 $t ACS chemical biology $x 1554-8937 $g Roč. 14, č. 6 (2019), s. 1110-1114
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31091068 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20200511 $b ABA008
991    __
$a 20200526083856 $b ABA008
999    __
$a ok $b bmc $g 1525219 $s 1096417
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 14 $c 6 $d 1110-1114 $e 20190516 $i 1554-8937 $m ACS chemical biology $n ACS Chem Biol $x MED00179502
GRA    __
$a C6563/A16771 $p Cancer Research UK $2 United Kingdom
GRA    __
$a 110578/Z/15/Z $p Wellcome Trust $2 United Kingdom
LZP    __
$a Pubmed-20200511

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...